Neuphoria Therapeutics Inc. (NEUP) income statement
NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
$2.28+0.01 (+0.44%)
Close on Nov 18, 2026Market cap $68.54KP/E –Yield –
Neuphoria Therapeutics Inc. financial ratios
See a number that looks wrong?